Estabrook Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Hold |
250
| – | – | 0.02% | 137 |
|
|
2025
Q1 | $159K | Hold |
250
| – | – | 0.03% | 124 |
|
|
2024
Q4 | $178K | Hold |
250
| – | – | 0.03% | 124 |
|
|
2024
Q3 | $263K | Hold |
250
| – | – | 0.04% | 119 |
|
|
2024
Q2 | $263K | Hold |
250
| – | – | 0.04% | 120 |
|
|
2024
Q1 | $241K | Hold |
250
| – | – | 0.04% | 125 |
|
|
2023
Q4 | $220K | Hold |
250
| – | – | 0.04% | 126 |
|
|
2023
Q3 | $206K | Sell |
250
-30
| -11% | -$24.7K | 0.04% | 129 |
|
|
2023
Q2 | $201K | Hold |
280
| – | – | 0.03% | 133 |
|
|
2023
Q1 | $230K | Hold |
280
| – | – | 0.04% | 130 |
|
|
2022
Q4 | $202K | Hold |
280
| – | – | 0.03% | 135 |
|
|
2022
Q3 | $193K | Hold |
280
| – | – | 0.04% | 134 |
|
|
2022
Q2 | $166K | Hold |
280
| – | – | 0.03% | 141 |
|
|
2022
Q1 | $196K | Hold |
280
| – | – | 0.03% | 138 |
|
|
2021
Q4 | $177K | Buy |
280
+30
| +12% | +$18.9K | 0.03% | 148 |
|
|
2021
Q3 | $151K | Hold |
250
| – | – | 0.02% | 142 |
|
|
2021
Q2 | $140K | Hold |
250
| – | – | 0.02% | 150 |
|
|
2021
Q1 | $118K | Hold |
250
| – | – | 0.02% | 160 |
|
|
2020
Q4 | $121K | Buy |
+250
| New | +$121K | 0.02% | 153 |
|